Marksans Pharma gets EIR from USFDA for New York unit
- Country:
- India
Marksans Pharma on Tuesday said it has received an establishment inspection report (EIR) from the US health regulator for company's manufacturing facility in the US.
In a regulatory filing, the company announced "receipt of the EIR from US Food and Drug Administration (USFDA) in respect of inspection of company's manufacturing facility Time-Cap Laboratories Inc. located at Farmingdale, New York, USA carried out from December 5, 2019 to December 18, 2019".
The shares of the company were trading at Rs 23.20 apiece on BSE, up 4.98 percent from the previous close.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
ALSO READ
Magnitude 5.5 earthquake strikes New York, New Jersey - EMSC
Indian student dies in US state of Ohio: Indian consulate in New York
Magnitude 4.8 earthquake hits New York City region, USGS says
Earthquake shakes New York City area with preliminary magnitude of 4.8, officials say, reports AP.
Earthquake shakes New York City area
Google News